Prices of ASX stocks are not being updated. The latest IIQ price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

Intrinsic Value

The intrinsic value of INOVIQ Ltd (IIQ) under the Base Case is 0.08 AUD per share. Compared with the last price of 0.14 AUD on Oct 14, the stock appears Overvalued by 44% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

IIQ Intrinsic Value
AU$0.08
Overvaluation 44%
Intrinsic Value
Price AU$0.14
Alert me when IIQ is below its intrinsic value
Today AU$0.06 · 55.1% below the current price

IIQ is cheaper than usual. Still overvalued, but less so than on 82% of days in the past 5 years.

Alternatives to IIQ

Fundamental Analysis

What INOVIQ Does

Health Care

INOVIQ Ltd is an Australian life sciences company focused on cancer diagnostics and exosome-based tools. Its main work is to develop blood tests and related technologies that help detect cancer earlier, with a particular emphasis on ovarian and breast cancer. The company also works on exosome science, which uses tiny particles released by cells as a source of diagnostic and research information.

Headquarters
Australia AU
Employees
15
IPO date
Apr 18, 1991
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
INOVIQ Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one IIQ stock?

The intrinsic value for INOVIQ Ltd (IIQ) under the Base Case is 0.08 AUD.

Is IIQ stock undervalued or overvalued?

Compared with the last price of 0.14 AUD on Oct 14, the stock appears Overvalued by 44% .

Back to Top